La Jolla Pharmaceutical Company (LJPC)
NASDAQ: LJPC · IEX Real-Time Price · USD
3.16
+0.04 (1.28%)
At close: Jul 5, 2022 4:30 PM
3.31
+0.15 (4.75%)
Pre-market:
Jul 6, 2022 8:28 AM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
75.72 | 33.42 | 23.05 | 10.06 | 0 | 0.62 | 1.06 | 0 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY)
|
126.58% | 44.96% | 129.26% | - | - | -41.72% | - | - | - | - | Upgrade
|
| Cost of Revenue
|
13.49 | 7.82 | 2.39 | 1.64 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit
|
62.23 | 25.6 | 20.66 | 8.41 | 0 | 0.62 | 1.06 | 0 | 0 | 0 | Upgrade
|
| Selling, General & Admin
|
35.39 | 38.43 | 45.13 | 85.16 | 30.85 | 16.7 | 13.93 | 11.4 | 13.58 | 9.39 | Upgrade
|
| Research & Development
|
5.01 | 23.01 | 85.33 | 117.3 | 84.58 | 62.29 | 29.09 | 9.94 | 4.36 | 1.35 | Upgrade
|
| Operating Expenses
|
40.4 | 61.44 | 130.46 | 202.46 | 115.43 | 78.99 | 43.03 | 21.34 | 17.94 | 10.74 | Upgrade
|
| Operating Income
|
21.83 | -35.84 | -109.8 | -194.05 | -115.43 | -78.37 | -41.97 | -21.34 | -17.94 | -10.74 | Upgrade
|
| Interest Expense / Income
|
10.46 | 10.05 | 10.77 | 7.3 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Expense / Income
|
-8.34 | -6.47 | -4.07 | -1.89 | -0.62 | -0.19 | -0.06 | -0.03 | -0.01 | -3 | Upgrade
|
| Pretax Income
|
19.71 | -39.42 | -116.51 | -199.47 | -114.8 | -78.19 | -41.91 | -21.31 | -17.94 | -7.74 | Upgrade
|
| Income Tax
|
0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income
|
19.66 | -39.42 | -116.51 | -199.47 | -114.8 | -78.19 | -41.91 | -21.31 | -17.94 | -7.74 | Upgrade
|
| Preferred Dividends
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 0.78 | Upgrade
|
| Net Income Common
|
19.66 | -39.42 | -116.51 | -199.47 | -114.8 | -78.19 | -41.91 | -21.31 | -18.74 | -8.52 | Upgrade
|
| Shares Outstanding (Basic)
|
27 | 27 | 27 | 25 | 21 | 17 | 16 | 11 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted)
|
34 | 27 | 27 | 25 | 21 | 17 | 16 | 11 | 2 | 0 | Upgrade
|
| Shares Change
|
25.06% | 0.80% | 6.65% | 19.83% | 23.14% | 10.08% | 46.72% | 592.66% | 655.18% | 2663.20% | Upgrade
|
| EPS (Basic)
|
0.72 | -1.44 | -4.30 | -7.85 | -5.41 | -4.54 | -2.68 | -2.00 | -12.16 | -41.77 | Upgrade
|
| EPS (Diluted)
|
0.58 | -1.44 | -4.30 | -7.85 | -5.41 | -4.54 | -2.68 | -2.00 | -12.16 | -41.77 | Upgrade
|
| Free Cash Flow Per Share
|
1.03 | -1.26 | -3.16 | -6.09 | -4.44 | -3.54 | -1.73 | -1.23 | -3.10 | -10.47 | Upgrade
|
| Gross Margin
|
82.19% | 76.60% | 89.62% | 83.66% | - | 100.00% | 100.00% | - | - | - | Upgrade
|
| Operating Margin
|
28.83% | -107.24% | -476.28% | -1929.70% | - | -12722.73% | -3970.58% | - | - | - | Upgrade
|
| Profit Margin
|
25.96% | -117.96% | -505.37% | -1983.58% | - | -12692.37% | -3965.18% | - | - | - | Upgrade
|
| Free Cash Flow Margin
|
37.29% | -103.44% | -371.51% | -1538.47% | - | -9890.75% | -2554.31% | - | - | - | Upgrade
|
| Effective Tax Rate
|
0.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| EBITDA
|
32.05 | -25.29 | -99.88 | -187.76 | -113.54 | -77.46 | -41.57 | -21.3 | -17.93 | -7.74 | Upgrade
|
| EBITDA Margin
|
42.32% | -75.66% | -433.22% | -1867.15% | - | -12573.86% | -3932.36% | - | - | - | Upgrade
|
| Depreciation & Amortization
|
1.88 | 4.08 | 5.86 | 4.41 | 1.27 | 0.73 | 0.35 | 0.02 | 0.01 | 0 | Upgrade
|
| EBIT
|
30.17 | -29.37 | -105.73 | -192.17 | -114.8 | -78.19 | -41.91 | -21.31 | -17.94 | -7.74 | Upgrade
|
| EBIT Margin
|
39.84% | -87.88% | -458.64% | -1910.96% | - | -12692.37% | -3965.18% | - | - | - | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).